Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Podocyte
by Highest Patent Value in the world in 2022

The Podocyte top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Podocyte Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Podocytes are cells in the Bowman's capsule in the kidneys that wrap around capillaries of the glomerulus. Podocyte cells make up the epithelial lining of Bowman's capsule, the third layer through which filtration of blood takes place. The Bowman's capsule filters the blood, retaining large molecules such as proteins while smaller molecules such as water, salts, and sugars are filtered as the first step in the formation of urine. Although various viscera have epithelial layers, the name visceral epithelial cells usually refers specifically to podocytes, which are specialized epithelial cells that reside in the visceral layer of the capsule.
#
Company Name
Region
Tech Topics
Total
1
Osaka, Japan
Medicine,Health care,Clinical trial,
...[+2]
Avg patent value: 7.96 M
2
Japan
Avg patent value: 7.96 M
3
Switzerland
Medicine,Health care,Drug,
...[+2]
Avg patent value: 1.97 M
4
Avg patent value: 1.71 M
5
Substance abuse,Hospitality industry,Health care,
...[+2]
Avg patent value: 847,500
6
Health care,Hospitality industry,Vascular Medicine,
...[+2]
Avg patent value: 847,500
7
Biopharmaceutical,Medicine,Health care,
...[+2]
Avg patent value: 520,000
8
Tokyo, Japan
Avg patent value: 200,000
9
Avg patent value: 118,800
10
Avg patent value: 91,000
11
Île-de-France, France
Avg patent value: 22,000
12
Avg patent value: 22,000
13
Île-de-France, France
Hospitality industry,Health care,Systemic scleroderma,
...[+2]
Avg patent value: 22,000
14
Avg patent value: 22,000
15
EA, GB
Asset management,Alternative investment,Gene delivery,
...[+2]
Avg patent value: 16,000
16
Avg patent value: 3,900
17
Pharmacy and Therapeutics,CTGF,Idiopathic pulmonary fibrosis,
...[+2]
Avg patent value: 0
18
Avg patent value: 0
19
Rhône-Alpes, France
Avg patent value: 0
20
United Kingdom
Asset management
Avg patent value: 0
Page generation time: Jul 17 2025